Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
27605055
DOI
10.1007/s00428-016-2018-6
PII: 10.1007/s00428-016-2018-6
Knihovny.cz E-zdroje
- Klíčová slova
- Dedifferentiation, High-grade transformation, Hybrid tumour, Salivary gland neoplasms, Salivary glands,
- MeSH
- dospělí MeSH
- geny myc genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorová transformace buněk patologie MeSH
- nádory slinných žláz diagnóza patologie MeSH
- prognóza MeSH
- sekundární malignity diagnóza patologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- stupeň nádoru MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Salivary gland hybrid tumour, first described in 1996, is a very rare neoplasm for which exact morphological criteria have not been universally agreed upon. In contrast, the concept of high-grade transformation (HGT) in salivary neoplasms has been widely accepted during the last decade, and the number of reported cases is rapidly increasing. A review of the literature revealed 38 cases of hybrid tumour reported in 22 publications. During approximately the same time period, well over 100 cases of HGT in salivary neoplasms have been reported. There are important histological similarities between hybrid tumours and salivary tumours with HGT. In the latter, containing one tumour component of low-grade malignancy and the other of high grade, the two tumour components are not entirely separated and appear to originate in the same area. Virtually, all cases reported as hybrid tumour had no clear lines of demarcation between the two tumour types. We are inclined to suggest that most of the 38 cases of hybrid tumours described in the literature would today better be called tumour with HGT rather than hybrid tumour. The relative proportion of the two components may vary, and the high-grade component is sometimes very small, which emphasises the importance of very generous sampling of the surgical specimen. The molecular genetic mechanisms responsible for HGT, including what used to be called hybrid tumour, remain largely unknown. Abnormalities of a few genes (including p53, C-MYC, cyclin D1, HER-2/neu) have been documented. As insufficient data exist on gene abnormalities in these lesions, conclusions as to whether or not they have a common origin and which mechanisms are involved in transformation cannot be drawn. Due to the small number of cases reported, many of which lack follow-up details; indicators of prognosis of hybrid tumours are not available, but their behaviour seems to be similar to that of tumours with HGT, i.e. an accelerated aggressive course. HGT of salivary gland neoplasms greatly influences macroscopic and microscopic evaluation of the specimen but also, given the high incidence of metastases and morbidity, carries significant treatment implications.
Zobrazit více v PubMed
Head Neck Pathol. 2012 Sep;6(3):373-6 PubMed
Ophthal Plast Reconstr Surg. 2011 Sep-Oct;27(5):e119-21 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Aug;86(2):188-95 PubMed
APMIS. 1996 Feb;104(2):99-102 PubMed
Cell Oncol (Dordr). 2011 Aug;34(4):369-79 PubMed
Otolaryngol Head Neck Surg. 1988 Feb;98(2):155-61 PubMed
Head Neck Pathol. 2012 Sep;6(3):389-94 PubMed
Arch Pathol Lab Med. 2000 Apr;124(4):494-6 PubMed
Hiroshima J Med Sci. 2001 Dec;50(4):101-4 PubMed
J Oral Maxillofac Pathol. 2013 Sep;17(3):474-7 PubMed
Histopathology. 1999 Oct;35(4):380-3 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May;121(5):542-549.e1 PubMed
Head Neck Pathol. 2013 Mar;7(1):85-92 PubMed
Pathol Int. 2003 Oct;53(10):704-9 PubMed
Lab Invest. 2014 Jun;94(6):692-702 PubMed
Balkan Med J. 2013 Sep;30(3):333-6 PubMed
Arch Pathol Lab Med. 1999 Aug;123(8):698-702 PubMed
Virchows Arch. 2006 Feb;448(2):204-8 PubMed
Int J Clin Exp Pathol. 2014 Dec 01;7(12):9008-22 PubMed
Head Neck Pathol. 2015 Jun;9(2):293-9 PubMed
Adv Ther. 2016 Mar;33(3):357-68 PubMed
Case Rep Otolaryngol. 2013;2013:385405 PubMed
Am J Surg Pathol. 2007 Nov;31(11):1683-94 PubMed
Histopathology. 2000 Sep;37(3):260-3 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):177-80 PubMed
Eur J Cancer B Oral Oncol. 1996 Jul;32B(4):251-9 PubMed
Histopathology. 1994 Nov;25(5):494-6 PubMed
Head Neck Pathol. 2013 Jul;7 Suppl 1:S37-47 PubMed
Brain Tumor Pathol. 2000;17 (3):159-63 PubMed
Hum Pathol. 1997 Jul;28(7):869-73 PubMed
Acta Otolaryngol. 2010;130(1):185-9 PubMed
Histopathology. 2002 Sep;41(3):250-9 PubMed
Eur Arch Otorhinolaryngol. 2003 Jul;260(6):312-5 PubMed
Case Rep Otolaryngol. 2014;2014:629054 PubMed
Cancer. 1971 Aug;28(2):461-6 PubMed
Case Rep Otolaryngol. 2015;2015:192453 PubMed
Virchows Arch. 1999 Apr;434(4):291-9 PubMed
Virchows Arch. 2006 Feb;448(2):236-8 PubMed
Hum Pathol. 2001 Dec;32(12):1403-7 PubMed
Ultrastruct Pathol. 1995 Sep-Oct;19(5):365-70 PubMed
Arch Pathol Lab Med. 2011 Jan;135(1):123-30 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jun;119(6):661-74 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jul;106(1):85-91 PubMed
Am J Surg Pathol. 2010 Sep;34(9):1258-65 PubMed
Head Neck Pathol. 2009 Dec;3(4):310-4 PubMed
Anticancer Res. 2013 Oct;33(10):4567-71 PubMed
Mod Pathol. 2003 Dec;16(12):1265-72 PubMed
J Clin Pathol. 2010 Jul;63(7):615-9 PubMed
Pathology. 2013 Dec;45(7):693-5 PubMed
Virchows Arch. 2004 Oct;445(4):425-8 PubMed
Mod Pathol. 2002 Jul;15(7):724-33 PubMed
Oncol Rep. 2011 Jul;26(1):3-11 PubMed
Head Neck Pathol. 2016 Jun;10 (2):152-60 PubMed
Histopathology. 2003 Dec;43(6):604-6 PubMed
Histopathology. 2009 Oct;55(4):472-5 PubMed
Oral Oncol. 2004 Mar;40(3):348-52 PubMed
Histopathology. 2000 Sep;37(3):283-4 PubMed
Hum Pathol. 2003 Oct;34(10):1068-72 PubMed
Virchows Arch. 1997 Jun;430(6):495-500 PubMed
Kulak Burun Bogaz Ihtis Derg. 2014 Jan-Feb;24(1):46-9 PubMed
Am J Surg Pathol. 1999 Apr;23(4):465-72 PubMed
Int J Gynecol Pathol. 2000 Oct;19(4):377-80 PubMed
J Oral Maxillofac Pathol. 2014 Jan;18(1):97-101 PubMed
Virchows Arch. 1999 Apr;434(4):361-5 PubMed
Anticancer Res. 2005 Mar-Apr;25(2B):1321-6 PubMed
Patholog Res Int. 2011;2011:325965 PubMed
Am J Surg Pathol. 2014 Jan;38(1):23-33 PubMed
Oral Oncol. 2009 Nov;45(11):e208-9 PubMed
Am J Surg Pathol. 2007 Jan;31(1):44-57 PubMed
Mod Pathol. 2012 Apr;25(4):529-36 PubMed
Am J Clin Pathol. 1999 Jun;111(6):785-91 PubMed
J Korean Med Sci. 2004 Jun;19(3):462-5 PubMed
Med Oral Patol Oral Cir Bucal. 2010 Jan 01;15(1):e43-7 PubMed
Am J Surg Pathol. 2009 Aug;33(8):1137-45 PubMed
Am J Surg Pathol. 2009 Sep;33(9):1322-9 PubMed
Development of head and neck pathology in Europe